What's New in Research Funding

Molecular structuresPage last updated October 17, 2018

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates:
 

October 17, 2018
 

  • EMHSeed: Call for Proposals: EMHSeed funding program seeks seeding innovative research partnerships between researchers in Engineering, in Medicine, and in the Toronto Academic Health Sciences Network (TAHSN). EMHSeed will fund new collaborative projects beginning as early as January 2019. Each project will bring together an Engineering coPI and a Medicine/TAHSN coPI. For additional details and eligibility requirements please refer to the Call for Proposals (attached). The annual budget for each EMHSeed project will be $60,000 CAD/year for a maximum of 2 years. This is the sum total of cash invested by the collaborating Faculties and units.  
    Applications are due by email to vdr@ecf.utoronto.ca by close of business November 27, 2018. Please include the word “XSeed” in the subject line. Complete submissions should include: 1) the completed Application Form (template attached), 2) Letters of support confirming financial contributions from partner Departments/Institutes, and 3) CV of co-PIs (e.g. CCV or NSERC Form 100).
    INFORMATION SESSION: Tuesday, November 6th in WB 215 (Wallberg Building -  180 College St.) from 1pm-2pm.
    EMH Seed Call for Proposals
    EMH Seed Application Form
     
  • Canadian Cancer Society. Deadline for full applications: January 15, 2019
    • Innovation Grants. The goal of this program is to support the development and testing of unconventional concepts and approaches to address problems in cancer research, enhance our understanding of cancer, and generate new approaches to confront the challenges we face in defeating cancer. Value: Up to $100,000 per year and a maximum of $200,000 per grant.
    • Innovation to Impact Grants. The goal of the Innovation program is to support the development and testing of unconventional concepts and approaches to address problems in cancer research, enhance our understanding of cancer, and generate new approaches to confront the challenges we face in defeating cancer. Value: Up to $150,000 per year for up to 3 years.
    • Travel Awards. A limited number of Travel Awards to PhD or MD/PhD students, and post-doctoral/medical/clinical fellows are available. Eligible expenses will not exceed $2,000.
       
  • Cancer Research Society: Operating Grants. The objective of the Operating Grant is to support fundamental, early translational, and environmental-cancer research on all types of cancer to contribute to the advancement of science aimed at preventing, detecting and treating this disease. Amount: $60,000 per year for two years. Deadline for Letters of Intent: December 4, 2018.
     
  • POGO Research Unit: Seed Funding. POGO offers annual seed funding grants of up to $15,000 to facilitate or support feasibilities studies, the development of preliminary data to enable applications to other granting agencies or self-contained studies. Deadline for registration form: October 31, 2018. The full application will be sent to applicants once they have registered. Full application deadline: December 15, 2018 at 4pm.
     
  • Varian Medical Systems: Artificial Intelligence (AI) in radiation oncology - Call for proposals. Varian Medical system seeks innovative research to develop new applications of AI in radiation oncology as well as techniques to build confidence in the clinical use of AI. All faculty with expertise in Artificial Intelligence (AI) are encouraged to apply. Applicants are not required to hold affiliations with a medical school or hospital. Faculty with a background in AI are encouraged to consider this opportunity. The RFP is best suited for investigators with a solid understanding of clinical needs in radiation oncology. Multi-disciplinary teams with combined technical and clinical expertise are encouraged, but not required. While there is no specified limit on requested funds, awards could range from $25,000 to $500,000. Read the full RFP to view topics of interest and submission guidelines. To request a grant application form or to submit any questions, please email: research.collaborations@varian.com
     
  • Mitacs-JSPS Summer Program: Call for Applications. The Mitacs-JSPS Summer Program, offered in partnership with the Japan Society for the Promotion of Science (JSPS) provides opportunities for graduate students and postdoctoral fellows in Canada to pursue collaborative research in Japan, allowing them to advance their own research while promoting scientific progress in both Japan and Canada. Mitacs is now accepting applications for the Mitacs-JSPS Summer Program, which supports researchers in Canada to undertake 10-week research projects in Japan in Summer 2019. The program is open to graduate students and postdoctoral fellows in all disciplines at Canadian universities. UofT internal deadline: November 28, 2018; Sponsor deadline: December 5, 2018.
     
  • JDRF Innovative Grants. Innovative grants provide one year of support for a maximum of USD $100,000 in direct costs and indirect costs of 10%, for a total of USD $110,000. Deadline for proposals: October 31, 2018.
  • Burroughs Wellcome Fund (BWF) - Physician Scientist Institutional Award (BWF initiative to help institutions address the shortage of physician-scientists). The Burroughs Wellcome Fund is offering a second round of the Physician-Scientist Institutional Awards (PSIA) program that was instituted in 2017 to increase the number of single degree M.D.’s who enter research. The PSIA advisory committee will review novel and innovative proposals demonstrating how institutions will utilize a $2.5 million grant from BWF that outlines opportunities and support for the M.D. (only) to pursue training, which will enable her/him to launch and continue a successful career as an independent investigator. Ten to 12 finalists will be selected and required to come to BWF headquarters in Research Triangle Park, NC for an interview on May 16/17, 2019. Up to five awards ($2,500,000 each) will be made in this program cycle. A one-step full application submission will be utilized with proposals due February 15, 2019.
     
  • Burroughs Wellcome Fund (BWF): Preterm Birth Initiative. This initiative was created to increase the understanding of the biological mechanisms underlying parturition and spontaneous preterm birth and will provide up to USD $500,000 over a four-year period (USD $125,000 per year). The initiative is designed to stimulate both creative individual scientists and multi-investigator teams to approach the problem of preterm birth using creative basic and translation science methods. Postdoctoral fellows nearing their transition to independent investigator status through senior established investigators are encouraged to apply. Deadline for applications: December 4, 2018.
     
  • Association for Frontotemporal Degeneration (AFTD): Treat FTD Fund. The Treat FTD Fund was launched in 2016 with the Alzheimer's Drug Discovery Foundation to support clinical trials testing novel or repurposed drugs for FTD disorders. Running clinical trials in FTD patients will enable investigators to identify optimal approaches to targeting this unique patient population. In addition, trials supported through the Treat FTD Fund will complement efforts such as the FTD Biomarkers initiative and the Accelerating Drug Discovery for FTD program by employing emergent advances in biomarker development and preclinical research. The targeted population should include both genetic and sporadic forms of any FTD disorder. Applications must include a clear description of the rationale for the mechanism of action in the targeted population. Budgets can be flexible and in the range of USD $500K to $2M for trials ranging from 1 - 3 years. Leveraging other sources of funding or other ongoing trials is encouraged. Partnerships /co-funding with industry or other foundations is acceptable. Deadline for Letters of Intent: November 9, 2018; Full application deadline: February 15, 2019.
  • Muscular Dystrophy Association (MDA): Translational Research. MVP funds projects from proof-of-principle studies through phase 2 trials. For-profit entities are required to contribute funds that match or exceed MDA's contribution. MDA will negotiate return on investment. Projects funded by MVP are milestone-driven projects, with funds released according to the completion of pre-agreed upon sections of the project. MVP will consider funding projects up to USD $1M, depending on the stage of research. MVP is interested in partnering with applicants to accelerate research on projects with strong institutional support, and in general MVP funds should constitute less than 50% of the total project budget. Deadline for Letters of Intent: December 1, 2018; March 1, 2019; June 1, 2019; and September 1, 2019.

  • Rally Foundation for Childhood Cancer Research: Collaborative Pediatric Cancer Research Awards Program. Rally funds research in the following areas: 
    - Under-studied cancer types 
    - Innovative approaches to childhood cancer research which could lead to advanced studies or clinical trials 
    - Studies that are likely to lead to a clinical trial, personalized, alternative, or integrated research proposals 
    - Quality of life and survivorship research proposals 
    Award categories include: Fellowship Grants; Investigator and Independent Investigator Research Grants; and Consortium Grants. Deadline for Letters of Intent: December 11, 2018; Full application deadline: January 11, 2019.
     

October 3, 2018
 

  • UofT Connaught Committee: Connaught New Researcher Awards. Up to $1,000,000 will be awarded in the 2018-19 academic year to help new tenure stream faculty members establish competitive research programs. Support for approximately 50 awards of up to $20,000 will be provided to the highest ranked proposals (No matching required). These awards are intended to establish a strong research program, thereby increasing the faculty member's competitiveness for external funding. Applications are to be made using the form available on the Connaught funding opportunities webpage and submitted electronically via MRA (My Research Applications) by December 3, 2018.  Applicants are encouraged to login well in advance of advance of the December 1st submission deadline to ensure that there are no problems with login credentials and to leave appropriate time for the routing and approval process. Full program details and application materials can be found on the Connaught website. Questions may be addressed to connaught.secretariat@utoronto.ca or 416-978-7118.
     
  • REMINDER: Community Partnership Research Program. Jointly funded by the University and the Connaught Fund. This initiative is intended to help create new collaborative research partnerships, or nurture early stage partnerships, between the University and community partners, fostering access to each other’s unique knowledge, expertise and capabilities on issues of shared interest that, over time, may evolve into more established relationships that will attract external funding through, for example, the SSHRC Partnerships Grant program. Partnership Projects can request up to $50,000 per year for one to three years. Through this competition, up to four partnership initiatives will be supported. This is a one-time funding initiative, to be revisited based on the success of the initial project, University of Toronto faculty members who are eligible to hold research funding are eligible to submit proposals in response to this call.  Proposed initiatives must include an organizing team that includes representatives of a lead community partner, including a co-leader for the initiative. Contact: Steven Hermans, Partnership Development Officer; Tel: 416-946-3606. Application Deadline: October 31, 2018. CPRP Program Guidelines and CPRP Application Instructions
     
  • Fulbright Canada Research Chairs: Visiting Chairs Program. Fulbright Canada Research Chairs are intended for Canadian citizens who are exceptional scholars and/or experienced professionals who wish to conduct research and/or lecture in the United States. Fulbright Canada Research Chairs are pre-arranged affiliations that allow scholars to conduct research/lecture on subjects important to that university. Partner universities are excited to welcome the Fulbright Visiting Chairs into campus life and encourage them to engage with students, faculty, and the broader community. Fulbright Visiting Research Chairs can guest lecture in university courses, mentor students, lecture in public venues, network, and promote their research, while representing the Fulbright program, and their home and host institutions. The Traditional Fulbright Student Award is also currently accepting applications from Canadian graduate students, prospective graduate students, or junior professionals looking to study or conduct research in the U.S. Deadline for both programs: November 15, 2018.
     
  • AGE-WELL Core Research Program (2020-2025) Request for Proposals (RFP). AGE-WELL is Canada’s Technology and Aging Network. The pan-Canadian Network brings together researchers, non-profits, industry, government, care providers, older adults and caregivers to develop technology-based solutions to support healthy aging. As AGE-WELL completes its first five-year mandate (2015-2020), the Network is developing its plans and goals for its next iteration, specifically from 2020-2025. A key aspect of this planning process is the development of AGE-WELL’s next Core Research Program, which is a set of integrated, long-term research projects that are the cornerstone of the Network’s activities. Visit the RFP for the overview of their 8 challenge areas and complete details. AGE-WELL has partnered with Mitacs and MEDTEQ to provide additional funding as part of this RFP. Additional partners and collaborators may join this funding initiative over the coming months. The maximum investment per Core Research Project is $200,000 per year (commencing April 1, 2020) for a minimum of 3 to a maximum of 5 years, for a maximum of $1,000,000 per grant. Deadline for applications: January 4, 2019.
     
  • Ontario Centres of Excellence (OCE): their round of Ontario-Jiangsu Industrial Research and Development Program (OJIRDP). OJIRDP fosters opportunities for international industry-academic R&D collaborations that have an impact in both Ontario and in the Jiangsu province of China. A partnership of the Jiangsu Science and Technology Department (JSTD), Ontario Centres of Excellence (OCE) and the Ontario Ministry of Economic Development, Job Creation and Trade (MEDJCT), OJIRDP supports projects leading to commercial success and economic benefits for both jurisdictions.
    Priority Fields - The current call for proposals will accept project applications focusing on the following technology sectors:
     1.    Information and Communication Technology (ICT): Business Analytics, Security, Enterprise Applications, Software, Design and Development Tools, Broadband Access, Enterprise Networking, Home Networking, Mobile Applications, NGN & Convergence, Optical Networking, Telecom Applications, VoIP & IP Telephony, Wireless Applications and Wireless Infrastructure
     2.    Life Sciences: Agrobiotech, Bioinformatics, Biologicals, Diagnostics, Healthcare IT, Industrial, Medical Devices, Telemedicine and Therapeutics
    UofT Internal deadline: November 6, 2018; Sponsor deadline: November 13, 2018.
    *INFORMATION SESSION*:
     OCE invites you to join us for an information session for the OJIRDP program via teleconference (Skype for Business) on Thursday, October 25, 2018 at 11:00 a.m. - 12:00 p.m.
     
  • Weston Brain Institute: Alzheimer's and related diseases. 
    INFORMATION WEBINAR: October 16, 2018, 1pm - 2pm EDT.

    •   Rapid Response Canada 2019: To provide seed funding for novel, high-risk, high-reward, translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging. A maximum of $200,000 over up to 18 months per project. Deadline for Letters of Intent: December 3, 2018.
    •  Transformational Research Canada 2019:  To provide funding for translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging. Value: A maximum of $1,500,000 over up to 3 years per project. Deadline Letters of Intent: December 3, 2018.
     
  • Prostate Cancer Canada: Discovery Grants. This funding scheme aims to support novel and innovative prostate cancer research that will lead to new lines of investigation. The proposed research project must be in the area of prostate cancer and may address any of the broad areas of prostate cancer research, including but not limited to: Biomedical; clinical; population health; health services/economics. Value: Up to $200,000 over two years. Registration deadline: November 30, 2018; Application deadline: January 17, 2019. 
     
  • Canadian Blood Services: BloodTechNet Award Program. The objective of this program is to facilitate the development of innovative educational projects that network the transfusion, cellular therapy, and transplantation communities in Canada. To achieve this objective, the Program supports projects delivering educational tools and resources that support the development of skills, knowledge and expertise of the health professionals in
    this network. Amount: Up to $50,000 for one year. Deadline for applications: November 30, 2018.
     
  • France Canada Research Fund (FCRF)- New Collaborations. This program provides financing for new scientific projects jointly developed by French and Canadian teams that have never worked together before.
    The financing is awarded to two-year projects in amounts ranging from $8,000 to $15,000, according to the needs expressed by the principal investigators. You can apply to the 2019 “New Collaborations” FCRF program using the following forms below. Please read the guidelines and visit UofT's funding opportunity here to download the letter of interest and the application forms. UofT Internal deadline for Letters of Intent: Monday, October 22, 2018; Sponsor deadline: November 16, 2018. 
     
  • Humboldt Association of Canada Kolleg on ‘Transitions’: Call for Papers. The year 2019 marks the 250th birth anniversary of Alexander von Humboldt. To celebrate this event, the Humboldt Association of Canada (HAC) is happy to announce a Kolleg to be held between May 9 to 11, 2019 at the University of Ottawa. The theme of this symposium will be ‘Transitions’. They invite Canadian Humboldians and researchers to submit abstracts to the Kolleg and present their interpretations of the word, ’Transitions’. The symposium will also provide an opportunity for researchers to learn more about AvH programs and funding assistance. Deadline for abstracts: October 15, 2018.
     
  • Alzheimer's Drug Discovery Foundation (ADDF): The Treat FTD (Frontotemporal Degeneration) Fund. The purpose of the Treat FTD Fund is a to support clinical development of novel or repurposed drugs for FTD disorders. Running clinical trials in FTD patients will enable investigators to identify optimal approaches to targeting this unique patient population. In addition, trials supported by the Treat FTD Fund will complement efforts such as the FTD Biomarkers Initiative and the Accelerating Drug Discovery for FTD program by employing emergent advances in biomarker development and preclinical research. Average Award: USD $500,000-$2,000,000, for 1-3 years. Leveraging other sources of funding is encouraged. Deadline for Letters of Intent: November 9, 2018. 
     
  • National PKU Alliance (Phenylketonuria research).
    •   Research Proposals. The NPKUA Fund is a campaign of the NPKUA to advance the science of PKU by funding the most promising research that will lead to new therapy discoveries and a cure. Amount: Up to USD $110,000 over two years. 
    •  Post-Doctoral Fellowships. Eligible applicants must have a Ph.D., M.D., or equivalent degrees and have an opportunity to hold a full-time fellowship position at an established academic/research institution in the US or worldwide. Amount: USD $55,000 per year for two years.
    Deadline for proposals: November 1, 2018.
     
  • Patient-Centered Outcomes Research Institute (PCORI).
    •   Addressing Disparities. Topics: 1. Improving Perinatal Outcomes for Low-Income African-American Women and Infants; 2. Diagnosis, Initiation of Treatment, and Retention of African Americans and Hispanics/Latinos along the HIV Care Continuum; 3. Interventions to Reduce Disparities in Obstructive Sleep Apnea (OSA) and Insomnia in Racial and Ethnic Minority Populations. Amount: Up to USD $3M for up to 3 years. Applicant Town Hall: October 18, 12:00 pm to 01:00 pm EDT . Deadline for Letters of Intent: November 6, 2018.
    •  Improving Methods for Conducting Patient-Centered Outcomes Research (PCOR). PCORI seeks to fund projects that address important methodological gaps and lead to improvements in the strength and quality of evidence generated by PCOR and comparative effectiveness research (CER). studies. Amount: Up to USD $750,000 for up to 3 years. Applicant Town Hall: October 24, 12:00 pm to 1:00 pm EDT . Deadline for Letters of Intent: November 6, 2018.
     
  • Harry J. Lloyd Charitable Trust: Melanoma Research Grants. Grants are awarded in three areas: Career Development, Basic Science, and Translational Research. With a special focus on screening and prevention, most individual grants do not exceed USD $125,000 per year. Deadline for applications: November 1, 2018.
     
  • Chan Zuckerberg Initiative: RFA - Seed Networks for the Human Cell Atlas. The Chan Zuckerberg Initiative invites applications for three-year projects to form Seed Networks for the Human Cell Atlas (HCA). The HCA is a global effort to create a reference map of all cell types in the human body. It is an ambitious goal to generate a fundamental reference for biomedical research. Seed Networks should consist of at least three principal investigators, including at least one computational biologist or software engineer, together with additional computational biologists, engineers, experimental biologists, and/or physicians. Deadline for applications: November 13, 2018.
     
  • American Society of Clinical Oncology (ASCO)/Conquer Cancer Foundation: Advanced Clinical Research Award (ACRA). The Advanced Clinical Research Award (ACRA) is a topic-specific competition designed to support physician-scientists committed to performing original, clinical cancer research in an area not currently funded. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Amount: USD $450,000 over 3 years. Deadline for applications: October 15, 2018.

     

September 19, 2018
 

  • PSI Graham Farquharson Knowledge Translation Fellowship 2019. This Fellowship is intended to provide salary support for a new Ontario investigator, who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship’s funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research. All applications for this funding opportunity must be made through the Faculty of Medicine Research Office and are subject to internal review. All applications must include the completed PSIF application form and adhere to the guidelines provided. Only two applications will be selected for submission and formally endorsed by the institution. Faculty of Medicine, UofT internal deadline: Thursday, October 11, 2018 at 9am. See our webpage for eligibility, guidelines, and how to apply. Further information and to see examples, please see PSI's website.
  • PSI Research Trainee Fellowship 2019. The primary aim of this fellowship is to provide highly qualified Medical Doctors (M.D.) with clinically applicable research training opportunities and support. (Please note: this funding opportunity is not an additional PSI operating grant.). Applicants must be an M.D. in a Ph.D. or MSc. Program, or in a combined M.D./Ph.D. or MSc. Program, or In the Clinician Investigator Program (CIP). All applications for this funding opportunity must be made through the Faculty of Medicine Research Office and are subject to internal review. All applications must include the completed PSIF application form and adhere to the guidelines provided. Only two applications will be selected for submission and formally endorsed by the institution. Faculty of Medicine, UofT internal deadline: Tuesday, October 9, 2018 at 9am. See our webpage for eligibility, guidelines, and how to apply. Further information and to see examples, please see PSI's website.

  • Drug Discovery Bootcamp. If you are a scientist in an academic institute or an early stage biotech company doing translational research that enables innovative medicines for patients – we invite you to join us for a Drug Discovery Bootcamp on October 24th, 2018 at MaRS Discovery District. The event will be FREE to registered participants and will start at 9 am and run until 2 pm. The agenda and registration information can be found here. Questions should be directed to Kevin Canning at MaRS Innovation - kcanning@marsinnovation.com or 647-260-7844.

  • Hong Kong University – University of Toronto Call for Joint Research Proposals 2018. University of Hong Kong (HKU) and the University of Toronto (U of T) are contributing matching funds to support collaborative education and research initiatives through a joint call for proposals. To be eligible, a proposal must include team participants from both institutions. Up to four (4) successful proposals will be funded.
    HKU will provide each approved project up to the sterling equivalent of  $100,000 HK (~$16,000 CAD) dollars  per year to support HKU applicants. U of T will provide each approved project up to $100,000 HK (~$16,000 CAD) dollars per year to support U of T applicants. The maximum duration of each project is 12 months. All fields will be accepted. Deadline for proposals: October 1, 2018.

  • CIHR, NSERC, SSHRC and the Canada Foundation for Innovation: INVITATION FOR FEEDBACK - Prioritizing Future Challenges for Canada. The granting agencies are seeking your expertise to help prioritize which future challenges identified through a recent horizon scan are considered most important for Canada. The scan has identified 16 future challenges. We are seeking your expertise to help prioritize which challenges are considered most important for Canada. We ask that you select one top challenge, and explore its possible impacts. For the challenge you select, you will be asked a series of questions. You will then have the option of repeating the exercise for the challenge you deem of next-most importance. Beyond the 16 challenges identified in the horizon scan, you have the opportunity to identify additional challenges deemed critical to Canada’s future. Get started

  • Canadian Hemophilia Society (CHS): Research Programs. Deadline for applications: November 15, 2018.
    •    Dream of Cure Research Program : Applicants are invited to apply for basic scientific research grants in fields relevant to hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders.
    •    CHS/Pfizer Care Until Cure Research Program: This program allows Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders, including outcome evaluation. Grants are awarded for clinical research in fields relevant to improving the quality of life for persons with hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C, and carriers of an inherited bleeding disorder.
    •    CHS/Novo Nordisk Canada Psychosocial Research Program: This program was created to engage professionals/graduate students from the allied health disciplines (ie. Nursing, Physiotherapy & Social Work) in research activities addressed to understanding the psychosocial impact of hemophilia and other inherited bleeding disorders and to improve the quality of life of persons and families whose lives are affected by these disorders.

  • IC-IMPACTS, RHI, and ISIC: Canada-India Spinal Cord Injury (SCI) Innovation Award – Getting Solutions to Market. The competition seeks to attract innovators, medical practitioners and researchers in Indian and Canadian universities/institutes to work collaboratively across borders, develop and commercialize innovative technologies in the treatment and care of people who are living with SCI and associated secondary complications. Upper amount: $50,000 over 18-24 months. Deadline for Letters of Intent: September 30, 2018.

  • 2019 Alzheimer Society Research Program Competition. New Investigator Grants and Regular Research Grants are both available. Visit their website for details. Deadline for applications: November 9, 2018.

  • Thrasher Research Fund: E.W. "AI" Thrasher Awards. Ideal applications for the E.W. "Al" Thrasher Award address significant health problems that affect children in large numbers and offer the potential for practical solutions to these problems. Such solutions should be innovative and have the potential for broad applicability with low financial and/or technical barriers to implementation. Hypothesis-driven research is preferred over exploratory, hypothesis-generating research. Projects with a shorter distance to clinical applicability are given priority. Deadline for concept papers/proposals: Continuous.

  • Muscular Dystrophy Association: Clinical Research.  Applications are accepted on a rolling basis.
    •   Clinical Research Network Grants. Grants to MDA Clinical Research Centers will total USD $60,000 per center per year. Grants will be awarded for a 3 year period but will be renewed annually.
    •   Human Clinical Trial Grants. Human Clinical Trial Grants are designed to support both clinical trials of compounds already on the market and clinical research studies performed at academic medical centers. Trials of novel therapeutics should be submitted as MDA Venture Philanthropy (MVP) projects. MVP commonly supports for-profit entities and return-on-investment is negotiated by MDA. Upper amount: USD $26,000.

  • Mendez National Institute of Transplantation Foundation. the MNITF awards grants semiannually to researchers through our Research Grant Program (RGP), in order to improve clinical outcomes and positively impact the field of transplantation. Upper amount USD $150,000. Deadline for Letters of Inquiry: November 1, 2018.

  • Foundation Fighting Blindness.
    •   Program Project Award (PPA) - NEW. The PPA is intended to enable studies that are too large or complex for a single investigator to undertake in a reasonable amount of time and to address gaps in our current knowledge or therapeutic options. The PPA must be unified around a single, well-articulated hypothesis and a clearly defined deliverable(s), relevant to the mission of FFB. The teams supported by a PPA must be tightly integrated and sharply focused, freely share data and creative ideas, and each be essential to the common goal. Deadline for Letters of Intent: November 1, 2018.
    •  Ted and Elaine Welp Enhanced Career Development Award - Enhanced Research and Clinical Training for Physicians in Inherited Orphan Retinal Degenerative Diseases. This program for enhanced research and clinical training is intended to support a strong pool of clinician-scientists with a commitment to clinical research on inherited orphan retinal degenerative diseases. Upper amount: USD $510,000 over 3 years. Application deadline: October 31, 2018.

  • Cancer Research Institute (CRI).
    •   Technology Impact Award. This award provides seed funding to be used over 12-24 months to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies. Upper amount: USD $200,000. Deadline for Letters of Intent: November 15, 2018.
    •  Clinic and Laboratory Integration Program (CLIP) Grants. CRI offers its CLIP Grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The program supports basic, pre-clinical, and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. Upper amount: USD $200,000 over 2 years. Deadline for Letters of Intent: November 1, 2018.

  • Marsha Rivkin Center for Ovarian Cancer: Pilot Study Awards and Scientific Scholar Awards. Pilot Study awards are open to investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered. Upper amount: USD $75,000 for one year. Scientific Scholar Awards are intended to assist promising laboratory and clinical scientists in pursuing a career as an independent investigator in ovarian cancer research. Upper amount: USD $120,000 over two years. Deadline for applications: December 3, 2018.

  • Autism Science Foundation (ASF): Pre- and Postdoctoral Training Awards & Medical Student Gap Year Training Awards. The proposed training should be scientifically linked to autism but may be broadened to include training in a closely related area of scientific research. Autism Science Foundation will consider all areas of related basic and clinical research including but not limited to: human behavior across the lifespan (language, learning, behavior, communication, social function, motor skills & planning, epilepsy, sleep, repetitive disorders), neurobiology (anatomy, development, neuroimaging), pharmacology, behavioral intervention, neuropathology, genetics and gene/environment interactions, epigenetics, genomics, epigenomics, immunology, molecular and cellular mechanisms, studies employing model organisms and systems, and studies of treatment and service delivery. Deadline for applications: December 3, 2018.
     

September 7, 2018
 

  • Pfizer Partnering Workshop. The Innovations & Partnerships Office (IPO) at the University of Toronto is pleased to host the External Science and Innovation (ES&I) team from Pfizer. Representatives from Pfizer will be giving a presentation on how Pfizer engages in flexible academic partnering models for drug development, sponsored research, early stage seed funding, licensing and start-up support!
    DATE: Thursday, October 18, 2018 from 9am-10:30am
    LOCATION
    : University of Toronto, OnRamp Space, 1st Floor, Banting Institute, 100 College Street, Toronto. Register here
    There is also an opportunity to have a one-on-one meeting with Pfizer. See here for details.
     
  • Project Management for Research Course. Project management is vital to the success of research projects. The University of Toronto Division of the Vice-President Research and Innovation (VPRI) and the School of Continuing Studies have partnered to offer a course in project management specifically designed to provide the foundations to support the successful execution of research projects. Project management - tailored for research - is an important skill that can reduce risk, delineate key project deliverables and increase the likelihood of research project success. This course was designed for faculty researchers, staff scientists, post-doctoral fellows, research coordinators and those interested in a path to management and research leadership. Information and registration can be found at 3382 Project Management for Research for the Fall course starting September 21, 2018.
    Tuition Assistance: Please check the University’s web page for information on Educational Assistance Programs for Faculty and Staff regarding financial assistance for course tuition.
     
  • Banting and Best Diabetes Centre: BBDC Pilot and Feasibility Grants 2019/2020. This program provides funding of up to $40,000 per application to enable eligible investigators to explore new initiatives in the area of biomedical research/basic sciences.  This funding is not to be used as bridging or emergency funding, nor is it intended as funding for ongoing studies. To be eligible to apply, the principal applicant must hold a faculty appointment with the University of Toronto at the level of associate, assistant, or full professor. Those who received a 2018/2019 BBDC Pilot and Feasibility Grant as principal applicant are not eligible to apply for this competition as a principal or co-applicant. Deadline for applications: November 13, 2018.
     
  • NSERC Commercialization Grants: Idea to Innovation (I2I) program. Four times per year, the Natural Sciences and Engineering Research Council (NSERC) accepts applications for its “Idea to Innovation” (I2I) program, for the purpose of accelerating pre-competitive technologies for transfer to a Canadian company. Successful applicants receive awards of up to $125,000 for each phase of their commercialization project, with additional funding available as the project progresses. For more information please contact Hema Prabhu at innovations.partnerships@utoronto.ca or NSERC's websiteUofT internal deadline: September 14, 2018; Sponsor deadline: September 24, 2018.
     
  • SSHRC Partnership programs: Information Session. SSHRC Partnership suite of programs - Partnership Engage, Partnership Development & Partnership Stage 1 - Information Session. Research Services will hold an information workshop for the upcoming Partnership Engage Grants, Partnership Development Grants and Partnership Stage 1 Grants competitions. Professor Elspeth Brown, a selection committee member, will discuss the adjudication process and the elements of a strong proposal. There will also be advice on proposal preparation from our editorial team.
    DATE: Tuesday, September 11, 2018 from 9:00am - 11am.
    LOCATION: Governing Council Chamber, Simcoe Hall, 27 King's College Circle. RSVP by noon September 10th to sja.scott@utoronto.ca.
     
  • CIHR: Human Immunology Research Teams. CIHR, Crohn’s and Colitis Canada, JDRF Canada, Lupus Canada and Mitacs has launched The Human Immunology Initiative, divided into two distinct funding opportunities: 1) The Standardization Core; and 2) The Human Immunology Research Teams. The overall goal of this initiative is to create a coordinated workforce in human immunology research and build capacity to develop standardized methods to test novel therapeutic approaches in human immunology research. The Standardization Core has funded a team to advance the development of standardized procedures. CIHR is now launching the second opportunity, The Human Immunology Research Teams. Deadline for Letters of Intent: October 16, 2018.
     
  • National Sanitarium Association: NSA Scholars Program. The association funds research at the cutting edge of respirology, including chronic obstructive pulmonary disease, pneumonia, tuberculosis, and lung cancer. The NSA Scholars Program funds highly promising new researchers  who, at the time of application, are within the first three years of their first faculty appointment as independent investigators, and who have demonstrated considerable potential for success during their research training. They would be involved in research of the type described above. It is anticipated that Scholars may be working with colleagues who share complementary research interests, but the Scholar will be expected to add a distinctly new direction or innovative dimension to the group in an emerging area of importance. Maximum amount: $100,000 per year for five years. Deadline for applications: October 15, 2018.
     
  • Alpha Phi Foundation: 2019 Heart to Heart grant program. This program aims to provide $100,000 in grant funding to support innovative research studies and educational programs that aim to inform health care professionals and women about the causes, prevention and treatment of heart disease. Deadline for applications: November 2, 2018. Potential applicants are encouraged to attend a Q&A webinar with Alpha Phi Foundation Program Manager on Wednesday September 12, 2018 at 1:00PM Central Standard Time. 
     
  • National Vulvodynia Association: NVA Medical Research Fund. The NVA is seeking research proposals on the causes or treatment of Generalized Vulvodynia. Grants made through NVA's Medical Research Fund provide scientists with the opportunity to gather vital pilot data, which they need to secure funding from larger institutions such as NIH. Upper amount $50,000 USD (direct costs only). Deadline for Letters of Intent: September 21, 2018.
     
  • Michael J. Fox Foundation (MJJF): Improved Biomarkers and Clinical Outcome Measures Program. Funding will be directed to projects that will improve the precision of measuring Parkinson's disease in humans. This could include enriching subject populations in clinical trials, developing markers of target engagement, or discovery or validation of objective outcomes that track disease progression. Applications must focus on developing robust and precise biomarker measures (e.g., imaging, physiological or biochemical assays), clinical outcome measures, and/or scale development (e.g. predictive modeling) for PD. Amount: One to three year grants, up to $750,000 USD. Deadline for preliminary proposals: September 26, 2018.
     
  • National Organization for Rare Disorders Inc. (NORD): Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins. All U.S. and international researchers interested in studying these diseases are encouraged to consider applying. One grant of up to $50,000 USD is available. Deadline for applications: September 28, 2018.
     
  • BrightFocus Foundation: Alzheimer's Disease Research - Postdoctoral Fellowship awards and Standard Research Grants. Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards fund projects in an established laboratory that will serve as the basis for the applicant's own independent research career. Amount: $200,000 USD for 2 years. The Standard Award provides significant funding for researchers who have already generated some amount of preliminary data, but are often required to demonstrate additional, significant progress before they can apply to governmental or industrial funding agencies. Amount: $300,000 USD over 3 years. Deadline for applications: October 2, 2018.
     
  • U.S. Department of Defense (DOD): Psychological Health/Traumatic Brain Injury, Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award. The overarching goal of this effort is to improve our understanding of the impact of mild TBI (mTBI)/concussion on Service members and Veterans. The FY18 PH/TBIRP LIMBIC Award will support a Consortium conducting a single large longitudinal study and associated sub-studies within the scope of the Program Announcement/Funding Opportunity. The knowledge gained through the proposed studies will be used to inform TBI pathways of care and illuminate specific target areas to improve acute TBI care and subsequent support systems for chronic care following mTBI. All organizations, including international organizations, are eligible to apply. Upper amount $25M USD over 5 years. Deadline for pre-applications: October 8, 2018.
     
  • Oxalosis and Hyperoxaluria Foundation (OHF): Research Grants. The OHF seeks to support research that will ultimately lead to new diagnostics, treatments, and a cure for Primary Hyperoxaluria and related Hyperoxaluria conditions. Upper amount: $200,000 USD for up to 2 years. Deadline for applications: November 1, 2018.
     
  • Melanoma Research Alliance: Requests for Proposals. Pilot Awards support senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such "high-risk, high-reward" projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues. Upper amount: $100,000 USD for up to 2 years. Young Investigator and Established Investigator Awards, including Special Opportunity Awards are also available. Deadline for applications: November 2, 2018.
     
  • American Foundation for Suicide Prevention. Standard Innovation Grants are valued at $100,000 USD over 2 years. Priority area research applications are reviewed along with the general pool of grant applications, with priority given to strong grants in the designated areas: Opioids and Suicide; and Pain and Suicide. Distinguished Investigator Innovation Grants and Young Investigator Innovation Grants are also available. Deadline for applications: November 15, 2018.
     
  • Alzheimer's Research UK (ARUK): Global Clinical Trials Fund. The Global Clinical Trials Fund supports clinical trials that have potential to be of benefit to dementia patients. Lead applicants and trial sites can be from the UK or international. The remit of this scheme covers: 
    - Studies that aim to demonstrate target engagement, Phase I or Phase II clinical trials undertaken to ascertain the potential safety and efficacy of (novel or re-purposed) drug-based interventions in human subjects. 
    - Clinical trials of non-drug based, complex interventions. 
    - Opportunities for research 'add ons' to ongoing clinical trials (e.g. biomarker add-ons). 
    Upper amount: £1,000,000 GBP. Deadline for applications: November 14, 2018 or April 17, 2019.
     
  • Ataxia UK: Research Grants. Ataxia UK funds research of relevance to ataxia. Specifically it will only consider funding research into conditions in which ataxia is the principle symptom, and in which the ataxia is likely to be progressive. This includes conditions such as Friedreich's ataxia, the spinocerebellar ataxias and other cerebellar ataxias (including idiopathic ones). It does not include conditions such as multiple sclerosis, ataxic cerebral palsy, or other conditions in which ataxic symptoms are present as the result of another underlying condition. Upper amount: £70,000 GBP total for up to 3 years. Ataxia UK would be willing to consider applications with immediate potential benefit to people with ataxia from researchers based outside of the UK and Europe.  Deadline for pre-applications: October 17, 2018.

August 10, 2018
 

  • CIHR Information Session (hosted by the University of Toronto). The Research Services Office will hold an information session on the upcoming CIHR Foundation and Project grant competitions for Fall 2018.
    The session will cover program and eligibility requirements, changes for the 2018 competitions, navigating the ResearchNet and Canadian Common CV (CCV) systems, and other tips for submitting a strong application. Expert guest speaker Dr. Leah Cowen, Professor in the Department of Molecular Genetics, will provide insight into the application process and elements of a strong proposal through the lens of both a successful grantee and past reviewer.
    Please RSVP by no later than 12:00 p.m. on Wednesday, August 15th to Rocket Ship Weir at rs.weir@utoronto.ca.  Space is limited, so please be sure to RSVP as soon as possible. Please note there is a remote access option. Details can be found here
    DATE: Friday, August 17, 2018 from 1pm-2:30pm.
    Location: University of Toronto Bahen Centre, Room 1130, 40 St. George Street
     
  • 2018 NSERC Discovery Grant and RTI Information Sessions (hosted by the University of Toronto). We are pleased to offer Information Sessions to UofT faculty applying to this fall's NSERC Discovery Grant program or this fall's NSERC RTI Grant program. Topics will include each program's application requirements, eligibility, changes for this year’s competitions, evaluation criteria and proposal development.  These sessions will also include guest speakers (committee member or a successful applicant) who will outline details in the application and evaluation process.
    The Discovery Grant and RTI Info Sessions will be held on the following dates and locations: 
    St. George - Discovery only: September 5 from 1pm-3pm. Galbraith Building, Room 119, 35 St. George Street.
    St. George - RTI only: September 8 from 1pm - 2:30pm. VPRES McMurrich Meeting Room, 1st floor, 12 Queen's Park Crescent West.
    Visit here for further details and registration information, as well as for UTM and UTSC dates and locations.
     
  • Canada Research Coordinating Committee (CRCC): Consultation. The CRCC is launching a national consultation to reinvigorate Canada’s support for science and to position Canada as a global leader in research excellence. 
    This is an opportunity for Canadians, the research community and the next generation of scientists, scholars and students to help shape research in Canada. The vision for the future of Canada's research landscape is a bold, world-leading and highly coordinated system of federal support for science—a system that contributes to the social and economic well-being of Canadians.
    Share your views
    The CRCC invites your feedback on three key priorities:
    •    A new Tri-Agency Research Fund
    •    Strengthening equity, diversity and inclusion in research
    •    Support for early career researchers
    To learn more about each of these priorities, visit here.
    The initial consultation will close on August 27, 2018, and results will be shared shortly after this date for a further consultation.
     
  • Banting & Best Diabetes Centre (BBDC) Sun Life Financial Investigator Award for Diabetes Research 2018-2019This award is intended to support new clinician-scientists and basic scientists in the early stages of their careers. One Sun Life Financial New Investigator Award will be made available for this competition. Funds may be used for diabetes research support and/or the salary of a clinician-scientist conducting diabetes research.  
    For eligibility criteria, complete award details and application instructions, please visit their website. Questions should be directed to Rose LaBarbera at diabetes.bbdc@utoronto.ca, Tel: 416-978-4465.
    Deadline for applications: October 23, 2018 at 4pm.
  • REMINDER: NEW! ECHO (Entrepreneurship for Cardiovascular Health Opportunity) The Translational Biology & Engineering Program (TBEP) in partnership with the Health Innovation Hub (H2i) at the University of Toronto. ECHO is a specialized hands-on training program led by veteran entrepreneurs and consultants across a variety of sectors. ECHO provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, networking, and funding opportunities. Any Canadian-based student, researcher and/or entrepreneur developing advanced cardiovascular technologies and innovations is encouraged to apply. Deadline for applications: Friday, August 24, 2018.
     
  • University of Toronto - Connaught Innovation Award 2018-19. Approximately, 10-12 awards of up to $50,000 will be allocated in the 2018-19 competition to accelerate the development of promising technology and promote commercialization and/or knowledge transfer.  This year, Connaught applications will be at or above Technology Readiness Level (TRL) 4 as defined by Science and Economic Development Canada (SEDC) to support evolving the innovation to the next level with potential commercial partners.  Information regarding SEDC TRL Scale can be found here.  Successful projects will have strong socio-economic and/or commercial potential, and will strive to have a positive impact on society. For each project, a Notice of Intent (NOI) must be submitted to the Connaught Secretariat by September 10, 2018. Full applications are due by October 15, 2018. Projects must be based on inventions or research discoveries that are already disclosed to the University as of August 27, 2018. Full program details and application materials can be found on the Connaught Innovation Award page.
     
  • PSI Graham Farquharson Knowledge Translation Fellowship 2019. This Fellowship is intended to provide salary support for a new Ontario investigator, who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship’s funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research. All applications for this funding opportunity must be made through the Faculty of Medicine Research Office and are subject to internal review. All applications must include the completed PSIF application form and adhere to the guidelines provided. Only two applications will be selected for submission and formally endorsed by the institution. Faculty of Medicine, UofT internal deadline: Thursday, October 11, 2018 at 9am. See our webpage for eligibility, guidelines, and how to apply. Further information and to see examples, please see PSI's website.
  • PSI Research Trainee Fellowship 2019. The primary aim of this fellowship is to provide highly qualified Medical Doctors (M.D.) with clinically applicable research training opportunities and support. (Please note: this funding opportunity is not an additional PSI operating grant.). Applicants must be an M.D. in a Ph.D. or MSc. Program, or in a combined M.D./Ph.D. or MSc. Program, or In the Clinician Investigator Program (CIP). All applications for this funding opportunity must be made through the Faculty of Medicine Research Office and are subject to internal review. All applications must include the completed PSIF application form and adhere to the guidelines provided. Only two applications will be selected for submission and formally endorsed by the institution. Faculty of Medicine, UofT internal deadline: Tuesday, October 9, 2018 at 9am. See our webpage for eligibility, guidelines, and how to apply. Further information and to see examples, please see PSI's website.

  • CIHR Doctoral Awards. For this competition, applications will be accepted in all areas of health research, including biomedical, clinical, health services and social, cultural, environmental and population health.
    - Internal deadline for UofT applicants: September 25, 2018. (MRA needed from applicant's supervisor)
    - ResearchNet deadline for sponsor assessments: 48 hours prior to the CIHR deadline of October 2, 2018.
    PLEASE NOTE: The internal MRA requirement is for all applicants applying for this award through the University of Toronto. For all other applicants, please contact the Research Office of the institution through which you are applying.
    CIHR INFORMATION SESSION for students: English: September 11, 2018 at 11am EST; French: September 12, 2018 at 11am EST. Register here.

  • CIHR Fellowship Awards. These awards provide support for highly qualified candidates at the post-PhD or post-health professional degree stages to add to their experience by engaging in health research either in Canada or abroad. For this competition, applications will be accepted in all areas of health research, including biomedical, clinical, health services and social, cultural, environmental and population health.
    - Internal deadline for UofT applicants: October 25, 2018. (MRA needed from applicant's supervisor)
    - ResearchNet deadline for sponsor assessments: 48 hours prior to the CIHR deadline of November 1, 2018.
    PLEASE NOTE: The internal MRA requirement is for all applicants applying for this award through the University of Toronto. For all other applicants, please contact the Research Office of the institution through which you are applying.
    CIHR INFORMATION SESSION for students: English: September 11, 2018 at 11am EST; French: September 12, 2018 at 11am EST. Register here.

  • Genome Canada: Genomic Applications Partnership Program (GAPP) Round 13. *NEW* Precision Health Initiative - Rare Diseases: Clinical Implementation Projects. 
    Genome Canada has launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step. In order to initiate this ambitious program, Genome Canada is encouraging the submission of projects to the GAPP. Details, timelines, and how to apply can be found on the  GAPP homepage or the UofT funding opportunity. Deadline for draft expressions of interest: August 20, 2018 (due at UofT Research Services Office and Ontario Genomics). Applicants interested in applying are encouraged to contact Shobha Ramsubir, Senior Manager, Business Development and Outreach at Ontario Genomics. 

  • The Kidney Foundation of Canada:
    - 2019 Biomedical Research Grant Competition. Biomedical Research Grants provide financial support to medical researchers to assist in defraying the operating costs of research, which may include the purchase of materials, supplies and equipment and the payment of laboratory assistants. Grants are available for one, two or three years, commencing July 1, for up to $50,000 per year. 
    - Special Research Project Grant:  Predictive Biomarkers. Applicants are invited to submit a proposal for a special project related to predictive biomarkers.  The value of this grant is $450,000 over 4 years, with a maximum of $112,500 per year.
    Registration deadline: September 1, 2018; Full application deadline: October 1, 2018.

  • Cystic Fibrosis Canada: 2018 Fall Research Competition. Cystic Fibrosis is now accepting applications for the following awards:
    - Early Career Investigator award
    - Fellowship award
    - Studentship award
    Internal deadline for UofT applicants: September 24, 2018. (MRA needed from applicant's supervisor)
    Cystic Fibrosis Canada's deadline for final applications on proposalCENTRAL: October 1, 2018.

  • Grand Challenges Canada: Stars in Global Health - Sexual & Reproductive Health and Rights. Through this initiative Grand Challenges Canada is seeking bold ideas for products, services and implementation models that could transform how persistent challenges in sexual and reproductive health and rights are addressed in low- and middle-income countries. The bold ideas are expected to improve the provision and use of comprehensive sexual and reproductive health services. Of particular interest to Grand Challenges Canada are innovations that both prevent and respond to: Sexual and gender-based violence; Child, early, and forced marriage. Amount $100,000 for up to 12 months. UofT Internal deadline: September 18, 2018; Sponsor deadline: September 20, 2018.

  • Weston Brain Institute: Upcoming webinars:
    Quantum and Watson for Drug discovery - presented by IBM:
    August 21, 11am - 1pm EDT. Register here.
    Collaborating with CDRD on the preclinical development of novel therapeutics in neuroscience:
    September 14, 3pm-4pm EDT. Register here.

  • Hepatology Research Fellowship. Fall 2018 Priority Announcement. The CIHR -INMD in partnership with the Canadian Association for the Study of Liver (CASL) and the Canadian Liver Foundation (CLF), will provide funding for applications that are determined to be relevant to the following research priority:  Project proposals involving clinical and/or basic research that will advance the understanding of liver disease and ultimately contribute to patient management and care in Canada. Deadline for applications: November 1, 2018.

  • Crohn`s and Colitis Foundation of America Inc. (CCFA): Biology of Fibrosis in IBD. The CCFA seeks to fund studies focused on investigating the biological mechanisms leading to, and protecting from, fibrosis in IBD. These studies should be built upon clinical observations and/or published evidence in human IBD. Particular interest will be on proposals that address one or more of the following areas: 
    - Pathophysiology of fibrosis based on documented patterns of gene expression 
    - Cell biological mechanisms of fibrosis - role of different cell types 
    - Biology of strictureplasty 
    A multidisciplinary approach is preferred, for example, studies including in vitro models (e.g. human intestinal organoids), analysis of human biopsies, animal models of fibrosis, biophysical studies, and imaging approaches. Upper amount USD $900,000 over 3 years. Deadline for applications: September 7, 2018.

  • Michael J. Fox Foundation for Parkinson Research (MJJF).
    - Target Advancement Program. These awards support research characterizing promising, novel PD-relevant targets or continuing target biology work on established PD targets. Preferred targets for this program already demonstrate links to PD in human patient populations. These awards are well-suited to projects in which hypothetical or experimental rationale for a target is compelling but limited, and study results can make the case for continuing (or discontinuing) a line of research. Funding available: 12 - 18 months grants up to USD $150,000.
    - Therapeutic Pipeline Program. The Therapeutic Pipeline Program is open to industry and academic investigators proposing novel approaches or repositioning approved or clinically safe therapies from non-PD indications. Therapeutic Pipeline awards support prospective studies or retrospective studies utilizing existing data in human biofluids. Funding available: Pre-Clinical - USD $100K - $500K, one to two-year grants. Clinical - USD $1M-$2M, two to three-year grants.
    Funding Opportunities Information WEBINAR: September 6 at 12pm. Register here.
    Deadline for preliminary proposals: September 26, 2018.

  • BrightFocus Foundation: Standard Research Grants. These awards provide significant funding for researchers who have already generated some amount of preliminary data, but are often required to demonstrate additional, significant progress before they can apply to government or industrial agencies.
    - Alzheimer`s Disease Research Standard Award. Amount: USD $300,000 over 3 years. Deadline for applications: October 2, 2018.
    - National Glaucoma Research Standard Award. Amount: USD $200,000 over 2 years. Deadline for applications: November 9, 2018. 

  • Angelman Syndrome Foundation: Open call for research proposals. Angelman syndrome is a neurodevelopmental disorder caused by deficiency of the ubiquitin protein ligase UBE3A in the brain. Applications in the preclinical, translational and clinical research areas that investigate all aspects of Angelman syndrome will be considered. Highest priority will be given to pilot projects to test new ideas about pathogenesis and therapeutics of Angelman syndrome, translational research and clinical research studies. Of particular interest to the ASF are studies related to communication, behavioral issues and identification of issues and treatments that impact the daily life of people with Angelman syndrome and their families. Amount: Up to USD $100K per year for up to two years. Deadline for applications: October 15, 2018.

  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.

 

 

Back to Top